Free Access
Issue
Med Sci (Paris)
Volume 27, Number 11, Novembre 2011
Page(s) 929 - 931
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20112711005
Published online 30 November 2011
  1. Duclos-Vallée JC, Teicher E, Vittecoq D, Samuel D. La transplantation hépatique chez les patients co-infectés VIH/VHC et VIH/VHB. Med Sci (Paris) 2007 ; 23 : 723–728. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Lindenbach BD, Thiel HJ, Rice CM. Flaviviridae, the viruses and their replication. Philadelphia : Lippincott-Raven , 2007 : 1101–1152. [Google Scholar]
  3. Zeisel MB, Fofana I, Fafi-Kremer S, et al. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol 2011 ; 54 : 566–576. [CrossRef] [PubMed] [Google Scholar]
  4. Tews BA, Cocquerel L. Occludine, une clé de plus pour l’entrée du virus de l’hépatite C. Med Sci (Paris) 2009 ; 25 : 549–551. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Harris HJ, Farquhar MJ, Mee CJ, et al. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol 2008 ; 82 : 5007–5020. [CrossRef] [PubMed] [Google Scholar]
  6. Krieger SE, Zeisel MB, Davis C, et al. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology 2010 ; 51 : 1144–1157. [CrossRef] [PubMed] [Google Scholar]
  7. Blanchard E, Belouzard S, Goueslain L, et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 2006 ; 80 : 6964–6972. [CrossRef] [PubMed] [Google Scholar]
  8. Pelkmans L, Fava E, Grabner H, et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 2005 ; 436 : 78–86. [CrossRef] [PubMed] [Google Scholar]
  9. Farquhar MJ, Harris HJ, Diskar M, et al. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. J Virol 2008 ; 82 : 8797–8811. [CrossRef] [PubMed] [Google Scholar]
  10. Trotard M, Lepère-Douard C, Régeard M, et al. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J 2009 ; 23 : 3780–3789. [CrossRef] [PubMed] [Google Scholar]
  11. Lupberger J, Zeisel MB, Xiao F, et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 2011 ; 17 : 589–595. [CrossRef] [PubMed] [Google Scholar]
  12. Reiss S, Rebhan I, Backes P, et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 2011 ; 9 : 32–45. [NASA ADS] [CrossRef] [EDP Sciences] [MathSciNet] [PubMed] [Google Scholar]
  13. Gerold G, Rice CM. Locking out hepatitis C. Nat Med 2011 ; 17 : 542–544. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.